How Should You Play Pfizer (PFE) After COVID-Flu Shot Setback?

Last week, Pfizer (PFE) and partner BioNTech (BNTX) announced that a phase III study evaluating an mRNA-based combination vaccine candidate against influenza and COVID-19 missed one of its two primary immunogenicity objectives.The study’s two primary immunogenicity objectives were to demonstrate that the antibody responses elicited by the combination vaccine against the SARS-CoV-2 strain and influenza A and B strain were non-inferior to standard of care (“SOC”).The combination vaccine demonstrated comparabl ...